Latest Sakar Healthcare stock price
Sakar Healthcare P/E Ratio
SAKAR • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
48.8
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
48.8
Current Price
₹388.90
EPS (TTM)
₹7.97
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
57.32
Sector Median
35.38
Sector Rank
#11 of 89
Sector Percentile
12.4%
Earnings Breakdown (TTM)
TTM EPS
₹8.97
Sept 2025
₹2.03
Mar 2025
₹2.66
Key P/E Ratio Insights for Sakar Healthcare
- Stock appears overvalued with PE of 48.8, suggesting caution for new investments
- Trading at discount to sector average PE of 57.32
View the SAKAR equity price for detailed stock performance.
Related Pages for Sakar Healthcare
Additional stock information and data for SAKAR
Sector P/E Ratio Comparison
Comparing Sakar Healthcare with other companies in Healthcare sector
Sector Average
57.32
Sector Median
35.38
Lowest P/E
9.01
Highest P/E
515.32
Companies
89
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |
| Lincoln Pharmaceuticals | LINCOLN | 12.02 | ₹974 | Low |
| QMS Medical Allied Servi… | QMSMEDI | 12.82 | ₹177 | Low |
| Take Solutions | TAKE | 13.15 | ₹638 | Low |
| Venus Remedies | VENUSREM | 14.27 | ₹995 | Low |
| Royal Sense | ROYAL | 14.5 | ₹96 | Low |
| Bliss GVS Pharma | BLISSGVS | 16.62 | ₹1,973 | Moderate |
| RPG Life Sciences | RPGLIFE | 17.94 | ₹3,861 | Moderate |